Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Non-cash Items (2021 - 2024)

Kezar Life Sciences' Non-cash Items history spans 4 years, with the latest figure at $367000.0 for Q3 2024.

  • For Q3 2024, Non-cash Items rose 664.58% year-over-year to $367000.0; the TTM value through Sep 2024 reached $367000.0, up 664.58%, while the annual FY2023 figure was $118000.0, 99.23% down from the prior year.
  • Non-cash Items for Q3 2024 was $367000.0 at Kezar Life Sciences, up from $63000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $80.2 million in Q1 2022 and bottomed at $48000.0 in Q3 2023.
  • The 4-year median for Non-cash Items is $9.0 million (2021), against an average of $19.2 million.
  • The largest annual shift saw Non-cash Items plummeted 99.81% in 2023 before it soared 664.58% in 2024.
  • A 4-year view of Non-cash Items shows it stood at $77.4 million in 2021, then plummeted by 80.08% to $15.4 million in 2022, then crashed by 99.23% to $118000.0 in 2023, then skyrocketed by 211.02% to $367000.0 in 2024.
  • Per Business Quant, the three most recent readings for KZR's Non-cash Items are $367000.0 (Q3 2024), $63000.0 (Q1 2024), and $118000.0 (Q4 2023).